NASDAQ:MYNZ
Mainz Biomed B.V. Stock Company Profile
$0.600
-0.0250 (-4.00%)
At Close: Jun 17, 2024
Information
Robert Koch Strasse 50
Mainz 55129
49 6131 554 2860
mainzbiomed.com
Industry: Diagnostics & Research
Sector: Healthcare
Description
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
